Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 3 1

Status

Completed 6Unknown 2Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 4NIH 1NETWORK 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Gynecologic 6Other neoplasm 2

Conditions

Uterine Cervical Neoplasms 5Uterine Cervical Dysplasia 3Precancerous Conditions 2Papillomavirus Infections 2Atypical Squamous Cells of the Cervix 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Interventional × Vaginal Smears × Clear all
NCT03713710 2022-11-16

HPV

University of Alabama at Birmingham

Phase NA Completed
335 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT01550783 2020-07-31

Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening

University of Washington

Phase NA Completed
1,335 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

NCT04072913 2019-08-28

MMP-HPV

University Hospital, Bordeaux

Phase NA Completed
216 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT03713697 2018-10-22

HPV

University of Alabama at Birmingham

Phase NA Completed
484 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT00003384 2015-05-29

Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer

GOG Foundation

Phase NA Completed
684 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Precancerous Conditions

NCT00462813 2013-08-07

Diindolylmethane in Treating Patients With Abnormal Cervical Cells

National Cancer Institute (NCI)

Phase 3 Completed
3,000 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡